Tabuk Pharma and Sandoz Announce Strategic Partnership to Support the Localization of Specialized Medicines in Saudi Arabia
Tabuk Pharma has signed a strategic partnership agreement with Sandoz, under the sponsorship of the Local Content and Government Procurement Authority (LCGPA), to support the localization of specialized pharmaceutical products in Saudi Arabia, contributing to the growth of local content, strengthening healthcare sector preparedness, and enhancing the sustainability of pharmaceutical supply chains.
The signing ceremony was held at the Authority’s headquarters in the presence of Mr. Abdulrahman bin Abdullah Al-Samari, CEO of the Authority, Mr. Sami bin Ali bin Hujailan, Executive Vice President for Development, and Dr. Ashraf Al-Qurain, Executive Director of Health Sectors Development. The partnership reflects a shared commitment to advancing pharmaceutical manufacturing capabilities and supporting the objectives of Saudi Vision 2030.
For more information, please visit the full announcement.